Citadel Advisors
THRN

Citadel Advisors’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Citadel Advisors’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,453
Closed -$89.9K – 15576
2023
Q1 		$89.9K Buy
19,453
+3,217
+20% +$14.2K ﹤0.01% 11416
2022
Q4 		$58.9K Buy
+16,236
New +$72K ﹤0.01% 11929
2022
Q3 		– Sell
-24,974
Closed -$121K – 13957
2022
Q2 		$121K Buy
+24,974
New +$152K ﹤0.01% 11216
2021
Q4 		– Sell
-28,265
Closed -$244K – 15114
2021
Q3 		$244K Buy
+28,265
New +$231K ﹤0.01% 11529

Other funds holding THRN

EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors's THRN Position: Q2 2023 in Review

Citadel Advisors sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q2 2023, closing a stake of 19,453 shares — an estimated $89.9K sold.

Citadel Advisors first reported a position in THRN in Q3 2021 and held it in 4 quarters. The position peaked at $244K in Q3 2021. 44 funds tracked by Wall St. Rank hold THRN as of Q2 2023.

  • Citadel Advisors reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 19,453 Thorne Healthtech, Inc. Common Stock shares in Q2 2023, an estimated $89.9K.
  • Citadel Advisors first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Citadel Advisors's Thorne Healthtech, Inc. Common Stock position peaked at $244K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.